Double-Blind Study
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial
Double-blind Study
Double-Blind Technic
Double-blind studies.
Double-Blind Test
Double-Blind Administration
Double-Blind Procedure
Double-blind deconvolution
Double-Blinded Study